<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2007-10-21" updated="2020-01-02">
  <drugbank-id primary="true">DB04959</drugbank-id>
  <name>Verpasep caltespen</name>
  <description>HspE7 is a recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from _Mycobacterium bovis_, and the human papilloma viral (HPV) protein E7. Hsp65, similar to other members of its family of proteins, elicits a strong immune response and may be used to design vaccines against a number of different cancers. E7 protein is involved in carcinogenesis of anal and cervical tumors, and represents a tumor antigen that may be specifically targeted by lymphocytes. It is being developed by StressGen Biotechnologies Corp.</description>
  <cas-number>295371-00-5</cas-number>
  <unii>Z7T0JI2E2I</unii>
  <state>solid</state>
  <groups>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A3073</ref-id>
        <pubmed-id>16691066</pubmed-id>
        <citation>Palefsky JM, Berry JM, Jay N, Krogstad M, Da Costa M, Darragh TM, Lee JY: A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS. 2006 May 12;20(8):1151-5.</citation>
      </article>
      <article>
        <ref-id>A3074</ref-id>
        <pubmed-id>11525566</pubmed-id>
        <citation>Hunt S: Technology evaluation: HspE7, StressGen Biotechnologies Corp. Curr Opin Mol Ther. 2001 Aug;3(4):413-7.</citation>
      </article>
      <article>
        <ref-id>A3075</ref-id>
        <pubmed-id>12006932</pubmed-id>
        <citation>Goldstone SE, Palefsky JM, Winnett MT, Neefe JR: Activity of HspE7, a novel immunotherapy, in patients with anogenital warts. Dis Colon Rectum. 2002 Apr;45(4):502-7.</citation>
      </article>
      <article>
        <ref-id>A3076</ref-id>
        <pubmed-id>15977424</pubmed-id>
        <citation>Maciag PC, Paterson Y: Technology evaluation: HspE7 (Stressgen). Curr Opin Mol Ther. 2005 Jun;7(3):256-63.</citation>
      </article>
      <article>
        <ref-id>A3077</ref-id>
        <pubmed-id>16240938</pubmed-id>
        <citation>Derkay CS, Smith RJ, McClay J, van Burik JA, Wiatrak BJ, Arnold J, Berger B, Neefe JR: HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol. 2005 Sep;114(9):730-7.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Investigated for use/treatment in anal dysplasia, cervical dysplasia/cancer, genital warts, HIV infection, infectious and parasitic disease (unspecified), pediatric indications, warts, and viral infection.</indication>
  <pharmacodynamics/>
  <mechanism-of-action>HspE7 works by efficiently delivering the E7 antigen to dendritic cells, which have a natural affinity for Hsp. Dendritic cells are known to be the most potent cells in the body for triggering immune responses. Coupling E7 to Hsp takes advantage of the Hsp receptors that dendritic cells express on their surface to introduce E7, as part of a larger fusion protein, into the dendritic cells. </mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">BCG65-E7</synonym>
    <synonym language="english" coder="">Heat-shock protein HSP 65 (Mycobacterium BCG) fusion protein with transcription factor E7 (human papillomavirus 16)</synonym>
    <synonym language="english" coder="">HPV 16 E7/HSP65 vaccine</synonym>
    <synonym language="english" coder="">HPV E7 Peptide Epitope Vaccine</synonym>
    <synonym language="english" coder="">HspE7</synonym>
    <synonym language="english" coder="inn/usan">Verpasep caltespen</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences>
    <sequence format="FASTA">&gt;VE7_HPV16 Protein E7 - Human papillomavirus type 16
MHGDTPTLHEYMLDLQPETTDLYCYEQLNDSSEEEDEIDGPAGQAEPDRAHYNIVTFCCK
CDSTLRLCVQSTHVDIRTLEDLLMGTLGIVCPICSQKP</sequence>
    <sequence format="FASTA">&gt;CH602_MYCBO 60 kDa chaperonin 2 - Mycobacterium bovis
MAKTIAYDEEARRGLERGLNALADAVKVTLGPKGRNVVLEKKWGAPTITNDGVSIAKEIE
LEDPYEKIGAELVKEVAKKTDDVAGDGTTTATVLAQALVREGLRNVAAGANPLGLKRGIE
KAVEKVTETLLKGAKEVETKEQIAATAAISAGDQSIGDLIAEAMDKVGNEGVITVEESNT
FGLQLELTEGMRFDKGYISGYFVTDPERQEAVLEDPYILLVSSKVSTVKDLLPLLEKVIG
AGKPLLIIAEDVEGEALSTLVVNKIRGTFKSVAVKAPGFGDRRKAMLQDMAILTGGQVIS
EEVGLTLENADLSLLGKARKVVVTKDETTIVEGAGDTDAIAGRVAQIRQEIENSDSDYDR
EKLQERLAKLAGGVAVIKAGAATEVELKERKHRIEDAVRNAKAAVEEGIVAGGGVTLLQA
APTLDELKLEGDEATGANIVKVALEAPLKQIAFNSGLEPGVVAEKVRNLPAGHGLNAQTG
VYEDLLAAGVADPVKVTRSALQNAASIAGLFLTTEAVVADKPEKEKASVPGGGDMGGMDF
</sequence>
  </sequences>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347909860</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>HspE7</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002459</id>
      <name>Keratin, type II cytoskeletal 7</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A14163</ref-id>
            <pubmed-id>12072504</pubmed-id>
            <citation>Kanduc D: Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7. J Virol. 2002 Jul;76(14):7040-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08729" source="Swiss-Prot">
        <name>Keratin, type II cytoskeletal 7</name>
        <general-function>Structural molecule activity</general-function>
        <specific-function>Blocks interferon-dependent interphase and stimulates DNA synthesis in cells. Involved in the translational regulation of the human papillomavirus type 16 E7 mRNA (HPV16 E7).</specific-function>
        <gene-name>KRT7</gene-name>
        <locus>12q12-q13</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.23</theoretical-pi>
        <molecular-weight>51385.11</molecular-weight>
        <chromosome-location>12</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:6445</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>KRT7</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AJ238246</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P08729</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>K2C7_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>CK-7</synonym>
          <synonym>Cytokeratin-7</synonym>
          <synonym>K7</synonym>
          <synonym>Keratin-7</synonym>
          <synonym>Sarcolectin</synonym>
          <synonym>SCL</synonym>
          <synonym>Type-II keratin Kb7</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037209|Keratin, type II cytoskeletal 7
MSIHFSSPVFTSRSAAFSGRGAQVRLSSARPGGLGSSSLYGLGASRPRVAVRSAYGGPVG
AGIREVTINQSLLAPLRLDADPSLQRVRQEESEQIKTLNNKFASFIDKVRFLEQQNKLLE
TKWTLLQEQKSAKSSRLPDIFEAQIAGLRGQLEALQVDGGRLEAELRSMQDVVEDFKNKY
EDEINHRTAAENEFVVLKKDVDAAYMSKVELEAKVDALNDEINFLRTLNETELTELQSQI
SDTSVVLSMDNSRSLDLDGIIAEVKAQYEEMAKCSRAEAEAWYQTKFETLQAQAGKHGDD
LRNTRNEISEMNRAIQRLQAEIDNIKNQRAKLEAAIAEAEERGELALKDARAKQEELEAA
LQRGKQDMARQLREYQELMSVKLALDIEIATYRKLLEGEESRLAGDGVGAVNISVMNSTG
GSSSGGGIGLTLGGTMGSNALSFSSSAGPGLLKAYSIRTASASRRSARD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011759|Keratin, type II cytoskeletal 7 (KRT7)
ATGTCCATCCACTTCAGCTCCCCGGTATTCACCTCGCGCTCAGCCGCCTTCTCGGGCCGC
GGCGCCCAGGTGCGCCTGAGCTCCGCTCGCCCCGGCGGCCTTGGCAGCAGCAGCCTCTAC
GGCCTCGGCGCCTCACGGCCGCGCGTGGCCGTGCGCTCTGCCTATGGGGGCCCGGTGGGC
GCCGGCATCCGCGAGGTCACCATTAACCAGAGCCTGCTGGCCCCGCTGCGGCTGGACGCC
GACCCCTCCCTCCAGCGGGTGCGCCAGGAGGAGAGCGAGCAGATCAAGACCCTCAACAAC
AAGTTTGCCTCCTTCATCGACAAGGTGCGGTTTCTGGAGCAGCAGAACAAGCTGCTGGAG
ACCAAGTGGACGCTGCTGCAGGAGCAGAAGTCGGCCAAGAGCAGCCGCCTCCCAGACATC
TTTGAGGCCCAGATTGCTGGCCTTCGGGGTCAGCTTGAGGCACTGCAGGTGGATGGGGGC
CGCCTGGAGGCGGAGCTGCGGAGCATGCAGGATGTGGTGGAGGACTTCAAGAATAAGTAC
GAAGATGAAATTAACCACCGCACAGCTGCTGAGAATGAGTTTGTGGTGCTGAAGAAGGAT
GTGGATGCTGCCTACATGAGCAAGGTGGAGCTGGAGGCCAAGGTGGATGCCCTGAATGAT
GAGATCAACTTCCTCAGGACCCTCAATGAGACGGAGTTGACAGAGCTGCAGTCCCAGATC
TCCGACACATCTGTGGTGCTGTCCATGGACAACAGTCGCTCCCTGGACCTGGACGGCATC
ATCGCTGAGGTCAAGGCGCAGTATGAGGAGATGGCCAAATGCAGCCGGGCTGAGGCTGAA
GCCTGGTACCAGACCAAGTTTGAGACCCTCCAGGCCCAGGCTGGGAAGCATGGGGACGAC
CTCCGGAATACCCGGAATGAGATTTCAGAGATGAACCGGGCCATCCAGAGGCTGCAGGCT
GAGATCGACAACATCAAGAACCAGCGTGCCAAGTTGGAGGCCGCCATTGCCGAGGCTGAG
GAGCGTGGGGAGCTGGCGCTCAAGGATGCTCGTGCCAAGCAGGAGGAGCTGGAAGCCGCC
CTGCAGCGGGGCAAGCAGGATATGGCACGGCAGCTGCGTGAGTACCAGGAACTCATGAGC
GTGAAGCTGGCCCTGGACATCGAGATCGCCACCTACCGCAAGCTGCTGGAGGGCGAGGAG
AGCCGGTTGGCTGGAGATGGAGTGGGAGCCGTGAATATCTCTGTGATGAATTCCACTGGT
GGCAGTAGCAGTGGCGGTGGCATTGGGCTGACCCTCGGGGGAACCATGGGCAGCAATGCC
CTGAGCTTCTCCAGCAGTGCGGGTCCTGGGCTCCTGAAGGCTTATTCCATCCGGACCGCA
TCCGCCAGTCGCAGGAGTGCCCGCGACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00038</identifier>
            <name>Filament</name>
          </pfam>
          <pfam>
            <identifier>PF16208</identifier>
            <name>Keratin_2_head</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intermediate filament</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>keratin filament</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002460</id>
      <name>E3 ubiquitin-protein ligase UBR4</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A14164</ref-id>
            <pubmed-id>16061792</pubmed-id>
            <citation>Huh KW, DeMasi J, Ogawa H, Nakatani Y, Howley PM, Munger K: Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11492-7. Epub 2005 Aug 1.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q5T4S7" source="Swiss-Prot">
        <name>E3 ubiquitin-protein ligase UBR4</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization. Regulates integrin-mediated signaling. May play a role in activation of FAK in response to cell-matrix interactions. Mediates ubiquitination of ACLY, leading to its subsequent degradation.</specific-function>
        <gene-name>UBR4</gene-name>
        <locus>1p36.13</locus>
        <cellular-location>Membrane</cellular-location>
        <transmembrane-regions>850-870
993-1013</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>5.91</theoretical-pi>
        <molecular-weight>573835.26</molecular-weight>
        <chromosome-location>1</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:30313</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ZUBR1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF348492</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q5T4S7</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>UBR4_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.3.2.-</synonym>
          <synonym>600 kDa retinoblastoma protein-associated factor</synonym>
          <synonym>KIAA0462</synonym>
          <synonym>KIAA1307</synonym>
          <synonym>N-recognin-4</synonym>
          <synonym>p600</synonym>
          <synonym>RBAF600</synonym>
          <synonym>Retinoblastoma-associated factor of 600 kDa</synonym>
          <synonym>Zinc finger UBR1-type protein 1</synonym>
          <synonym>ZUBR1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004831|E3 ubiquitin-protein ligase UBR4
MATSGGEEAAAAAPAPGTPATGADTTPGWEVAVRPLLSASYSAFEMKELPQLVASVIESE
SEILHHEKQYEPFYSSFVALSTHYITTVCSLIPRNQLQSVAAACKVLIEFSLLRLENPDE
ACAVSQKHLILLIKGLCTGCSRLDRTEIITFTAMMKSAKLPQTVKTLSDVEDQKELASPV
SPELRQKEVQMNFLNQLTSVFNPRTVASQPISTQTLVEGENDEQSSTDQASAIKTKNVFI
AQNVASLQELGGSEKLLRVCLNLPYFLRYINRFQDAVLANSFFIMPATVADATAVRNGFH
SLVIDVTMALDTLSLPVLEPLNPSRLQDVTVLSLSCLYAGVSVATCMAILHVGSAQQVRT
GSTSSKEDDYESDAATIVQKCLEIYDMIGQAISSSRRAGGEHYQNFQLLGAWCLLNSLFL
ILNLSPTALADKGKEKDPLAALRVRDILSRTKEGVGSPKLGPGKGHQGFGVLSVILANHA
IKLLTSLFQDLQVEALHKGWETDGPPAALSIMAQSTSIQRIQRLIDSVPLMNLLLTLLST
SYRKACVLQRQRKGSMSSDASASTDSNTYYEDDFSSTEEDSSQDDDSEPILGQWFEETIS
PSKEKAAPPPPPPPPPLESSPRVKSPSKQAPGEKGNILASRKDPELFLGLASNILNFITS
SMLNSRNNFIRNYLSVSLSEHHMATLASIIKEVDKDGLKGSSDEEFAAALYHFNHSLVTS
DLQSPNLQNTLLQQLGVAPFSEGPWPLYIHPQSLSVLSRLLLIWQHKASAQGDPDVPECL
KVWDRFLSTMKQNALQGVVPSETEDLNVEHLQMLLLIFHNFTETGRRAILSLFVQIIQEL
SVNMDAQMRFVPLILARLLLIFDYLLHQYSKAPVYLFEQVQHNLLSPPFGWASGSQDSNS
RRATTPLYHGFKEVEENWSKHFSSDAVPHPRFYCVLSPEASEDDLNRLDSVACDVLFSKL
VKYDELYAALTALLAAGSQLDTVRRKENKNVTALEACALQYYFLILWRILGILPPSKTYI
NQLSMNSPEMSECDILHTLRWSSRLRISSYVNWIKDHLIKQGMKAEHASSLLELASTTKC
SSVKYDVEIVEEYFARQISSFCSIDCTTILQLHEIPSLQSIYTLDAAISKVQVSLDEHFS
KMAAETDPHKSSEITKNLLPATLQLIDTYASFTRAYLLQNFNEEGTTEKPSKEKLQGFAA
VLAIGSSRCKANTLGPTLVQNLPSSVQTVCESWNNINTNEFPNIGSWRNAFANDTIPSES
YISAVQAAHLGTLCSQSLPLAASLKHTLLSLVRLTGDLIVWSDEMNPPQVIRTLLPLLLE
SSTESVAEISSNSLERILGPAESDEFLARVYEKLITGCYNILANHADPNSGLDESILEEC
LQYLEKQLESSQARKAMEEFFSDSGELVQIMMATANENLSAKFCNRVLKFFTKLFQLTEK
SPNPSLLHLCGSLAQLACVEPVRLQAWLTRMTTSPPKDSDQLDVIQENRQLLQLLTTYIV
RENSQVGEGVCAVLLGTLTPMATEMLANGDGTGFPELMVVMATLASAGQGAGHLQLHNAA
VDWLSRCKKYLSQKNVVEKLNANVMHGKHVMILECTCHIMSYLADVTNALSQSNGQGPSH
LSVDGEERAIEVDSDWVEELAVEEEDSQAEDSDEDSLCNKLCTFTITQKEFMNQHWYHCH
TCKMVDGVGVCTVCAKVCHKDHEISYAKYGSFFCDCGAKEDGSCLALVKRTPSSGMSSTM
KESAFQSEPRISESLVRHASTSSPADKAKVTISDGKVADEEKPKKSSLCRTVEGCREELQ
NQANFSFAPLVLDMLNFLMDAIQTNFQQASAVGSSSRAQQALSELHTVEKAVEMTDQLMV
PTLGSQEGAFENVRMNYSGDQGQTIRQLISAHVLRRVAMCVLSSPHGRRQHLAVSHEKGK
ITVLQLSALLKQADSSKRKLTLTRLASAPVPFTVLSLTGNPCKEDYLAVCGLKDCHVLTF
SSSGSVSDHLVLHPQLATGNFIIKAVWLPGSQTELAIVTADFVKIYDLCVDALSPTFYFL
LPSSKIRDVTFLFNEEGKNIIVIMSSAGYIYTQLMEEASSAQQGPFYVTNVLEINHEDLK
DSNSQVAGGGVSVYYSHVLQMLFFSYCQGKSFAATISRTTLEVLQLFPINIKSSNGGSKT
SPALCQWSEVMNHPGLVCCVQQTTGVPLVVMVKPDTFLIQEIKTLPAKAKIQDMVAIRHT
ACNEQQRTTMILLCEDGSLRIYMANVENTSYWLQPSLQPSSVISIMKPVRKRKTATITTR
TSSQVTFPIDFFEHNQQLTDVEFGGNDLLQVYNAQQIKHRLNSTGMYVANTKPGGFTIEI
SNNNSTMVMTGMRIQIGTQAIERAPSYIEIFGRTMQLNLSRSRWFDFPFTREEALQADKK
LNLFIGASVDPAGVTMIDAVKIYGKTKEQFGWPDEPPEEFPSASVSNICPSNLNQSNGTG
DSDSAAPTTTSGTVLERLVVSSLEALESCFAVGPIIEKERNKNAAQELATLLLSLPAPAS
VQQQSKSLLASLHTSRSAYHSHKDQALLSKAVQCLNTSSKEGKDLDPEVFQRLVITARSI
AIMRPNNLVHFTESKLPQMETEGMDEGKEPQKQLEGDCCSFITQLVNHFWKLHASKPKNA
FLAPACLPGLTHIEATVNALVDIIHGYCTCELDCINTASKIYMQMLLCPDPAVSFSCKQA
LIRVLRPRNKRRHVTLPSSPRSNTPMGDKDDDDDDDADEKMQSSGIPNGGHIRQESQEQS
EVDHGDFEMVSESMVLETAENVNNGNPSPLEALLAGAEGFPPMLDIPPDADDETMVELAI
ALSLQQDQQGSSSSALGLQSLGLSGQAPSSSSLDAGTLSDTTASAPASDDEGSTAATDGS
TLRTSPADHGGSVGSESGGSAVDSVAGEHSVSGRSSAYGDATAEGHPAGPGSVSSSTGAI
STTTGHQEGDGSEGEGEGETEGDVHTSNRLHMVRLMLLERLLQTLPQLRNVGGVRAIPYM
QVILMLTTDLDGEDEKDKGALDNLLSQLIAELGMDKKDVSKKNERSALNEVHLVVMRLLS
VFMSRTKSGSKSSICESSSLISSATAAALLSSGAVDYCLHVLKSLLEYWKSQQNDEEPVA
TSQLLKPHTTSSPPDMSPFFLRQYVKGHAADVFEAYTQLLTEMVLRLPYQIKKITDTNSR
IPPPVFDHSWFYFLSEYLMIQQTPFVRRQVRKLLLFICGSKEKYRQLRDLHTLDSHVRGI
KKLLEEQGIFLRASVVTASSGSALQYDTLISLMEHLKACAEIAAQRTINWQKFCIKDDSV
LYFLLQVSFLVDEGVSPVLLQLLSCALCGSKVLAALAASSGSSSASSSSAPVAASSGQAT
TQSKSSTKKSKKEEKEKEKDGETSGSQEDQLCTALVNQLNKFADKETLIQFLRCFLLESN
SSSVRWQAHCLTLHIYRNSSKSQQELLLDLMWSIWPELPAYGRKAAQFVDLLGYFSLKTP
QTEKKLKEYSQKAVEILRTQNHILTNHPNSNIYNTLSGLVEFDGYYLESDPCLVCNNPEV
PFCYIKLSSIKVDTRYTTTQQVVKLIGSHTISKVTVKIGDLKRTKMVRTINLYYNNRTVQ
AIVELKNKPARWHKAKKVQLTPGQTEVKIDLPLPIVASNLMIEFADFYENYQASTETLQC
PRCSASVPANPGVCGNCGENVYQCHKCRSINYDEKDPFLCNACGFCKYARFDFMLYAKPC
CAVDPIENEEDRKKAVSNINTLLDKADRVYHQLMGHRPQLENLLCKVNEAAPEKPQDDSG
TAGGISSTSASVNRYILQLAQEYCGDCKNSFDELSKIIQKVFASRKELLEYDLQQREAAT
KSSRTSVQPTFTASQYRALSVLGCGHTSSTKCYGCASAVTEHCITLLRALATNPALRHIL
VSQGLIRELFDYNLRRGAAAMREEVRQLMCLLTRDNPEATQQMNDLIIGKVSTALKGHWA
NPDLASSLQYEMLLLTDSISKEDSCWELRLRCALSLFLMAVNIKTPVVVENITLMCLRIL
QKLIKPPAPTSKKNKDVPVEALTTVKPYCNEIHAQAQLWLKRDPKASYDAWKKCLPIRGI
DGNGKAPSKSELRHLYLTEKYVWRWKQFLSRRGKRTSPLDLKLGHNNWLRQVLFTPATQA
ARQAACTIVEALATIPSRKQQVLDLLTSYLDELSIAGECAAEYLALYQKLITSAHWKVYL
AARGVLPYVGNLITKEIARLLALEEATLSTDLQQGYALKSLTGLLSSFVEVESIKRHFKS
RLVGTVLNGYLCLRKLVVQRTKLIDETQDMLLEMLEDMTTGTESETKAFMAVCIETAKRY
NLDDYRTPVFIFERLCSIIYPEENEVTEFFVTLEKDPQQEDFLQGRMPGNPYSSNEPGIG
PLMRDIKNKICQDCDLVALLEDDSGMELLVNNKIISLDLPVAEVYKKVWCTTNEGEPMRI
VYRMRGLLGDATEEFIESLDSTTDEEEDEEEVYKMAGVMAQCGGLECMLNRLAGIRDFKQ
GRHLLTVLLKLFSYCVKVKVNRQQLVKLEMNTLNVMLGTLNLALVAEQESKDSGGAAVAE
QVLSIMEIILDESNAEPLSEDKGNLLLTGDKDQLVMLLDQINSTFVRSNPSVLQGLLRII
PYLSFGEVEKMQILVERFKPYCNFDKYDEDHSGDDKVFLDCFCKIAAGIKNNSNGHQLKD
LILQKGITQNALDYMKKHIPSAKNLDADIWKKFLSRPALPFILRLLRGLAIQHPGTQVLI
GTDSIPNLHKLEQVSSDEGIGTLAENLLEALREHPDVNKKIDAARRETRAEKKRMAMAMR
QKALGTLGMTTNEKGQVVTKTALLKQMEELIEEPGLTCCICREGYKFQPTKVLGIYTFTK
RVALEEMENKPRKQQGYSTVSHFNIVHYDCHLAAVRLARGREEWESAALQNANTKCNGLL
PVWGPHVPESAFATCLARHNTYLQECTGQREPTYQLNIHDIKLLFLRFAMEQSFSADTGG
GGRESNIHLIPYIIHTVLYVLNTTRATSREEKNLQGFLEQPKEKWVESAFEVDGPYYFTV
LALHILPPEQWRATRVEILRRLLVTSQARAVAPGGATRLTDKAVKDYSAYRSSLLFWALV
DLIYNMFKKVPTSNTEGGWSCSLAEYIRHNDMPIYEAADKALKTFQEEFMPVETFSEFLD
VAGLLSEITDPESFLKDLLNSVP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011760|E3 ubiquitin-protein ligase UBR4 (UBR4)
ATGGCGACGAGCGGCGGCGAAGAGGCGGCGGCAGCGGCTCCGGCGCCGGGGACCCCGGCA
ACGGGGGCGGACACGACCCCGGGCTGGGAGGTGGCTGTGCGGCCCCTGCTGTCCGCGTCC
TACTCCGCCTTCGAGATGAAGGAGTTGCCGCAGCTGGTGGCCTCAGTCATCGAGAGTGAA
TCAGAAATCCTGCACCATGAGAAGCAGTACGAGCCATTCTACTCATCTTTTGTTGCACTT
TCCACACACTATATTACAACAGTTTGCAGTCTCATTCCCCGGAACCAACTTCAGTCAGTG
GCAGCAGCCTGTAAAGTTCTAATTGAGTTTTCTCTCCTGCGTCTGGAGAATCCAGATGAG
GCTTGTGCTGTGTCCCAGAAACACTTGATTCTCCTAATCAAGGGCCTGTGCACTGGCTGT
AGCCGACTAGATAGAACTGAAATTATCACATTTACAGCAATGATGAAATCCGCCAAGCTG
CCCCAAACAGTGAAGACACTTTCAGACGTGGAAGATCAGAAAGAGCTGGCCTCACCAGTA
AGCCCTGAGTTGAGGCAAAAGGAGGTACAGATGAATTTTTTGAACCAGCTGACCTCAGTT
TTTAACCCTAGAACTGTAGCATCACAACCTATCAGTACACAGACTCTGGTGGAAGGAGAA
AATGATGAGCAGTCATCTACAGATCAAGCCTCAGCTATCAAAACCAAGAATGTGTTCATA
GCTCAGAACGTGGCTAGTCTTCAAGAGCTTGGTGGCTCGGAGAAGCTACTGCGTGTATGT
TTGAACCTGCCATATTTCCTACGCTATATCAATCGGTTCCAAGATGCAGTTTTAGCTAAT
TCCTTCTTCATAATGCCTGCAACAGTAGCAGATGCCACTGCTGTTCGTAATGGCTTTCAT
TCATTGGTGATTGATGTAACTATGGCATTGGATACCCTTTCTCTACCTGTGTTGGAACCT
CTCAATCCTTCTCGTCTACAAGATGTGACAGTCCTCAGCCTAAGTTGTCTGTATGCAGGT
GTGAGTGTGGCAACGTGCATGGCCATCCTCCATGTGGGTAGTGCCCAGCAAGTGCGGACA
GGGTCCACGAGCTCCAAAGAAGATGACTATGAAAGTGACGCAGCTACAATTGTCCAGAAA
TGTCTCGAAATCTATGACATGATTGGACAAGCAATCAGCAGTTCTCGCCGGGCTGGTGGT
GAGCACTATCAGAATTTCCAATTGCTGGGTGCTTGGTGCTTGTTAAACAGCCTTTTCCTC
ATACTGAACCTCAGTCCTACTGCGTTGGCTGATAAGGGGAAAGAGAAGGACCCACTGGCT
GCCCTCCGAGTCAGAGACATCCTTTCTCGTACTAAAGAGGGAGTGGGCTCCCCTAAACTG
GGGCCTGGAAAAGGGCATCAGGGATTTGGGGTACTCTCAGTAATATTGGCAAACCATGCC
ATCAAACTGCTAACGTCTCTCTTTCAAGACCTACAAGTGGAGGCCCTTCACAAGGGTTGG
GAGACAGATGGCCCCCCTGCAGCCTTGAGCATTATGGCCCAGAGCACCTCCATACAGAGG
ATTCAACGGCTGATTGACTCTGTCCCACTGATGAACCTGCTCTTGACGTTACTTTCAACT
TCCTACAGAAAGGCATGTGTCCTGCAGCGGCAGAGGAAGGGCTCCATGAGCAGCGATGCC
AGCGCCTCCACCGACTCCAATACTTACTATGAGGACGATTTCAGTAGCACGGAGGAGGAC
AGCAGCCAAGACGATGACAGTGAGCCTATTTTGGGGCAATGGTTTGAGGAGACTATTTCT
CCCAGTAAAGAGAAAGCAGCACCTCCGCCTCCTCCCCCACCTCCTCCACTGGAAAGCTCT
CCTCGGGTTAAAAGCCCCAGTAAGCAGGCCCCTGGTGAGAAGGGCAACATTCTGGCGAGT
CGCAAAGATCCTGAGTTGTTCTTAGGTCTGGCTTCCAACATTTTGAACTTCATCACCTCT
TCCATGCTGAACTCTCGGAACAATTTTATCCGAAACTATCTGAGTGTATCTCTTTCAGAA
CACCATATGGCCACCCTAGCCAGTATCATCAAGGAGGTGGACAAAGATGGACTCAAGGGT
TCATCAGATGAAGAGTTTGCTGCAGCTCTCTATCACTTCAACCACTCACTGGTAACCTCT
GACCTTCAGTCACCTAACCTGCAGAACACACTGTTGCAGCAGCTAGGAGTGGCTCCTTTT
TCTGAGGGCCCTTGGCCCTTGTACATTCACCCTCAAAGCCTCTCTGTGCTTTCACGCCTC
CTGCTCATCTGGCAACATAAAGCCAGTGCTCAAGGTGACCCTGACGTCCCAGAATGCCTT
AAAGTTTGGGACAGGTTTTTGTCTACAATGAAGCAGAATGCCCTGCAAGGTGTGGTGCCC
AGTGAGACAGAGGATCTGAATGTAGAACACCTGCAGATGCTCCTCCTCATTTTCCACAAT
TTCACCGAGACAGGCCGGCGGGCCATATTGTCGCTTTTTGTCCAGATCATCCAGGAGTTG
AGCGTCAACATGGATGCTCAGATGCGCTTCGTGCCGCTTATCTTGGCTCGCCTCCTTCTC
ATCTTTGATTATCTGCTTCATCAGTACTCCAAAGCCCCTGTGTATCTATTTGAGCAGGTA
CAGCATAACCTGCTAAGTCCTCCCTTTGGGTGGGCAAGTGGATCCCAGGACAGCAACAGC
CGCCGGGCAACCACTCCTCTCTATCATGGATTCAAAGAAGTAGAAGAAAACTGGTCTAAG
CATTTCTCATCAGATGCTGTCCCACACCCCAGATTCTACTGTGTCCTGTCCCCAGAAGCC
TCAGAGGATGATTTGAACCGACTTGATTCTGTGGCATGTGACGTCCTTTTCTCCAAGCTT
GTCAAGTATGATGAGCTTTATGCTGCACTGACAGCCCTGCTTGCAGCTGGGTCCCAGCTT
GATACAGTTAGGAGAAAGGAAAACAAGAATGTAACAGCCTTGGAGGCCTGTGCCCTTCAA
TATTACTTCTTGATACTGTGGAGGATCCTAGGAATTTTACCACCATCAAAGACTTACATT
AACCAGCTATCCATGAACTCACCTGAGATGAGCGAATGTGACATCTTGCACACTCTGCGA
TGGTCTTCTCGGCTCCGGATCAGCTCCTATGTCAACTGGATAAAGGATCACCTTATCAAA
CAGGGAATGAAGGCTGAGCATGCTAGCTCGCTTCTAGAACTGGCATCCACCACTAAGTGT
AGCTCAGTGAAATATGATGTTGAAATAGTAGAGGAATACTTCGCTCGACAGATCTCATCC
TTCTGTAGTATCGACTGTACCACCATCTTGCAGCTGCATGAAATTCCCAGTCTGCAGTCC
ATCTACACCCTTGATGCCGCGATCTCAAAGGTCCAGGTCTCTTTGGATGAGCATTTTTCT
AAGATGGCTGCTGAGACTGATCCTCATAAGTCGTCTGAGATTACCAAGAACCTACTTCCA
GCCACGCTGCAACTCATTGACACCTATGCATCGTTCACCAGAGCCTATTTGCTGCAAAAC
TTTAATGAAGAGGGAACAACTGAGAAACCTTCCAAGGAGAAACTGCAAGGCTTTGCTGCT
GTTTTGGCTATTGGCTCTAGCAGGTGCAAGGCAAATACTCTGGGTCCGACACTGGTTCAG
AATTTGCCATCGTCAGTGCAGACTGTGTGTGAGTCCTGGAACAACATCAATACCAATGAA
TTTCCCAATATTGGATCCTGGCGCAATGCCTTTGCCAATGACACCATCCCTTCAGAGAGT
TATATTAGTGCAGTGCAGGCTGCACACCTGGGGACTCTCTGTAGCCAAAGTCTGCCCCTG
GCTGCTTCCCTGAAGCATACCCTCCTCTCACTGGTCAGGTTGACTGGAGATCTTATTGTT
TGGTCAGATGAGATGAACCCACCACAGGTAATTCGGACACTGCTACCTCTTCTTTTGGAA
TCAAGCACTGAGAGTGTTGCCGAGATCAGTAGCAACTCCCTGGAACGCATCTTGGGCCCT
GCTGAGTCTGATGAGTTCTTGGCTCGTGTTTATGAGAAGCTGATCACTGGTTGTTACAAC
ATTCTGGCCAATCATGCAGATCCTAACAGTGGACTGGATGAATCCATCCTGGAGGAATGT
CTCCAGTACTTGGAAAAGCAGCTGGAAAGTAGCCAGGCTCGTAAAGCTATGGAGGAGTTT
TTCTCTGACAGTGGAGAACTTGTACAGATCATGATGGCAACAGCCAATGAGAACCTCTCT
GCTAAATTCTGTAACCGAGTTTTGAAATTCTTCACCAAACTCTTCCAGCTGACTGAGAAG
AGCCCTAACCCGAGCCTGTTGCATCTCTGTGGCTCCCTGGCACAACTGGCCTGTGTGGAA
CCTGTGCGCCTGCAGGCCTGGCTCACCCGCATGACTACATCGCCCCCAAAAGATTCTGAT
CAGCTGGATGTAATTCAGGAGAACCGGCAGCTGCTGCAGTTACTGACCACATACATTGTT
CGGGAAAACAGCCAAGTTGGGGAAGGTGTGTGTGCTGTTCTTCTGGGCACCCTGACTCCC
ATGGCAACAGAGATGCTGGCCAACGGTGATGGGACTGGCTTCCCTGAACTTATGGTTGTG
ATGGCCACTCTGGCCAGTGCAGGTCAAGGTGCTGGTCACCTTCAGCTTCATAATGCTGCT
GTGGATTGGCTGAGCAGATGCAAGAAATACCTGTCACAGAAGAATGTAGTTGAAAAACTG
AATGCCAATGTAATGCATGGAAAGCATGTGATGATCTTGGAGTGCACATGCCATATCATG
TCTTACTTGGCTGATGTCACGAATGCCCTGAGCCAGAGTAATGGTCAAGGCCCAAGTCAT
CTCTCAGTGGATGGGGAAGAGCGGGCCATTGAAGTAGACTCAGACTGGGTGGAGGAGTTG
GCGGTGGAAGAGGAAGATTCCCAGGCTGAGGATTCAGATGAAGATTCTCTTTGCAATAAA
CTCTGCACTTTTACGATCACACAGAAAGAATTCATGAACCAGCATTGGTACCACTGTCAC
ACCTGTAAAATGGTGGATGGCGTGGGTGTCTGCACAGTGTGTGCTAAGGTGTGCCACAAG
GATCATGAGATTTCCTATGCCAAGTATGGATCCTTCTTCTGTGACTGTGGAGCCAAGGAA
GATGGCAGCTGTTTGGCTCTGGTGAAGAGAACTCCTAGCAGTGGCATGAGCTCTACCATG
AAGGAGTCGGCATTTCAGAGTGAACCCAGGATTTCAGAGAGTCTAGTGCGTCATGCCAGC
ACCTCCTCGCCAGCTGACAAAGCCAAGGTTACCATCAGTGATGGAAAGGTTGCTGACGAA
GAGAAGCCCAAGAAGAGCAGCCTCTGCCGCACAGTAGAGGGCTGCCGGGAGGAATTACAG
AACCAGGCCAATTTCTCCTTCGCTCCTCTCGTGTTAGACATGCTTAATTTCCTTATGGAT
GCCATTCAGACCAACTTCCAGCAAGCTTCAGCCGTCGGGAGCAGCAGCCGTGCTCAGCAA
GCCCTCAGTGAGCTACACACTGTGGAGAAGGCAGTGGAGATGACAGACCAGCTGATGGTT
CCCACCTTAGGGTCCCAGGAAGGTGCCTTTGAGAATGTGCGGATGAATTACAGTGGAGAC
CAGGGCCAGACCATCCGGCAGCTGATCAGTGCTCATGTGCTCAGGCGGGTGGCTATGTGT
GTGCTCTCCTCTCCCCATGGGCGCCGCCAACATTTGGCTGTCAGCCATGAGAAGGGCAAG
ATCACCGTTCTGCAGCTCTCTGCACTCCTGAAGCAAGCAGATTCCAGCAAAAGGAAGTTA
ACTCTGACCCGCTTGGCTTCTGCCCCAGTTCCTTTTACTGTGTTGAGCCTCACAGGAAAT
CCCTGCAAGGAAGACTACTTGGCGGTTTGTGGGCTAAAGGACTGTCATGTGCTCACCTTT
AGTAGCTCAGGCTCTGTTTCGGATCACTTGGTTTTGCACCCTCAGTTGGCAACGGGGAAC
TTCATCATCAAAGCCGTGTGGTTACCTGGTTCACAGACCGAGTTAGCAATTGTCACCGCA
GACTTTGTTAAGATTTATGACCTGTGTGTTGATGCCTTGAGTCCAACCTTCTATTTTCTC
CTGCCAAGCTCAAAGATAAGAGATGTTACCTTCCTTTTCAATGAGGAGGGAAAGAACATC
ATTGTTATAATGTCTTCGGCTGGGTACATCTATACTCAGCTTATGGAAGAGGCCAGCAGT
GCCCAGCAGGGACCCTTCTATGTCACTAATGTGTTGGAAATCAATCATGAGGACCTGAAG
GACAGTAACAGCCAGGTGGCGGGCGGTGGTGTGTCCGTGTACTACTCCCACGTGTTGCAG
ATGTTGTTCTTCAGCTATTGTCAAGGCAAATCATTCGCAGCCACCATCAGCAGGACAACC
CTGGAGGTGTTGCAACTCTTCCCCATCAACATCAAAAGTTCCAATGGTGGCAGTAAGACT
TCTCCTGCTCTTTGCCAGTGGTCTGAGGTGATGAACCACCCTGGCTTGGTGTGCTGTGTC
CAGCAAACTACAGGGGTGCCGCTGGTAGTTATGGTGAAACCAGACACTTTTCTTATCCAG
GAGATTAAGACTCTTCCTGCTAAAGCGAAGATCCAAGACATGGTTGCTATTAGGCACACG
GCCTGCAATGAGCAGCAGCGGACAACAATGATTCTGCTGTGTGAGGATGGCAGCCTGCGC
ATTTACATGGCCAACGTGGAGAACACCTCCTACTGGCTGCAGCCATCCCTGCAGCCCAGC
AGTGTCATCAGCATCATGAAGCCTGTTCGAAAGCGCAAAACAGCTACAATCACAACCCGC
ACGTCTAGCCAGGTGACTTTCCCCATTGACTTTTTTGAACACAACCAGCAGCTGACAGAT
GTGGAGTTTGGTGGTAACGACCTCCTACAGGTCTATAATGCACAACAGATAAAACACCGG
CTGAATTCCACTGGCATGTATGTGGCCAACACCAAGCCCGGAGGCTTCACCATTGAGATT
AGTAACAACAATAGCACTATGGTGATGACAGGCATGCGGATCCAGATTGGGACTCAAGCA
ATAGAACGGGCCCCGTCATATATCGAGATCTTCGGCAGAACTATGCAGCTCAACCTGAGT
CGCTCACGCTGGTTTGACTTCCCCTTCACCAGAGAAGAAGCCCTGCAGGCTGATAAGAAG
CTGAACCTCTTCATTGGGGCCTCGGTGGATCCAGCAGGTGTCACCATGATAGATGCTGTA
AAAATTTATGGCAAGACTAAGGAGCAGTTTGGCTGGCCTGATGAGCCCCCAGAAGAATTC
CCTTCTGCCTCTGTCAGCAACATCTGCCCTTCAAATCTGAACCAGAGCAACGGCACTGGA
GATAGCGACTCAGCTGCCCCCACTACGACCAGTGGAACTGTCCTGGAGAGGCTGGTTGTG
AGTTCTTTAGAAGCCCTGGAAAGCTGCTTTGCCGTTGGCCCAATCATCGAGAAGGAGAGA
AACAAGAATGCTGCTCAGGAGCTGGCCACTTTGCTGTTGTCCCTGCCAGCACCTGCCAGT
GTCCAGCAGCAGTCCAAGAGCCTTCTGGCCAGCCTGCACACCAGCCGCTCGGCCTACCAC
AGCCACAAGGATCAGGCCTTGCTGAGCAAAGCTGTGCAGTGTCTCAACACATCTAGCAAA
GAGGGCAAGGATTTGGACCCTGAGGTGTTCCAGAGGCTAGTGATCACAGCTCGCTCCATT
GCCATCATGCGCCCCAACAACCTTGTCCACTTTACGGAGTCAAAGCTGCCCCAGATGGAA
ACAGAAGGAATGGATGAAGGGAAGGAACCGCAGAAGCAGTTGGAAGGAGATTGCTGTAGT
TTCATCACCCAGCTTGTGAACCACTTCTGGAAACTCCATGCATCCAAACCCAAGAATGCC
TTCTTGGCACCTGCCTGCCTTCCAGGACTAACTCATATTGAAGCTACTGTCAATGCTCTG
GTGGACATCATCCATGGCTACTGTACCTGTGAGCTGGATTGTATTAACACAGCATCCAAG
ATCTACATGCAGATGCTCTTGTGTCCTGATCCTGCTGTGAGCTTCTCTTGTAAACAAGCT
CTAATTCGAGTCCTAAGGCCCAGGAACAAACGGAGACATGTGACTTTACCCTCTTCCCCT
CGAAGCAACACTCCAATGGGAGACAAGGATGATGATGACGATGATGATGCAGATGAGAAA
ATGCAGTCATCAGGGATCCCGAATGGTGGTCACATCCGTCAGGAAAGCCAGGAACAGAGT
GAGGTGGACCATGGAGATTTTGAGATGGTGTCTGAGTCGATGGTCCTGGAGACAGCTGAA
AATGTCAACAATGGCAACCCCTCTCCCCTGGAGGCCCTGCTGGCAGGCGCAGAGGGCTTC
CCCCCCATGCTGGACATCCCACCTGATGCAGATGACGAGACCATGGTTGAACTAGCCATT
GCCCTGAGCCTGCAGCAGGACCAACAAGGCAGCAGCAGCAGTGCCCTGGGCCTGCAGAGC
CTGGGACTGTCCGGCCAGGCACCCAGCTCTTCCTCTCTGGACGCAGGAACCCTCTCTGAC
ACCACAGCATCAGCTCCAGCCTCAGACGACGAGGGCAGTACAGCAGCGACAGATGGTTCT
ACCCTTCGGACCTCTCCTGCTGACCACGGTGGTAGTGTGGGCTCGGAGAGCGGGGGCAGT
GCAGTGGACTCAGTGGCTGGCGAGCACAGTGTATCTGGCCGGAGCAGTGCTTATGGCGAT
GCTACAGCTGAGGGGCATCCGGCTGGACCAGGAAGTGTCAGCTCAAGCACTGGAGCCATC
AGCACCACCACTGGGCACCAGGAGGGAGATGGCTCCGAGGGAGAAGGAGAAGGAGAAACT
GAAGGAGATGTCCACACTAGCAACAGGCTGCACATGGTCCGTCTAATGCTGTTGGAGAGA
TTACTGCAGACCCTGCCTCAATTACGAAACGTTGGCGGTGTCCGGGCCATCCCATACATG
CAGGTCATTCTAATGCTCACTACAGATCTGGATGGAGAAGATGAGAAAGACAAGGGGGCC
CTAGACAACCTGCTCTCCCAGCTTATTGCTGAGTTGGGTATGGATAAAAAGGATGTCTCC
AAGAAGAATGAGCGCAGCGCCCTGAATGAAGTCCATCTGGTAGTAATGAGACTCCTGAGT
GTCTTCATGTCCCGCACCAAATCTGGATCCAAGTCTTCCATATGTGAGTCATCTTCCCTC
ATCTCCAGTGCCACAGCAGCAGCTCTACTGAGCTCTGGGGCTGTGGACTACTGCCTGCAC
GTGCTCAAATCACTGCTGGAATATTGGAAGAGCCAACAGAATGACGAGGAGCCTGTGGCT
ACCAGCCAGTTGCTGAAACCACATACTACCTCCTCCCCACCTGACATGAGCCCATTCTTT
CTCCGCCAGTATGTGAAGGGTCATGCTGCTGATGTGTTTGAGGCCTATACTCAGCTTCTA
ACAGAAATGGTACTGAGGCTTCCTTACCAAATCAAAAAGATTACTGACACCAATTCTCGA
ATCCCACCTCCTGTCTTTGACCACTCGTGGTTTTACTTTCTCTCCGAGTACCTCATGATC
CAGCAGACTCCATTTGTGCGCCGTCAAGTCCGCAAACTTCTGCTCTTCATCTGTGGATCC
AAAGAGAAGTACCGCCAGCTCCGGGATTTGCACACCCTGGACTCTCACGTGCGTGGGATC
AAGAAGCTGCTAGAAGAGCAGGGGATATTCCTCCGGGCAAGTGTGGTTACAGCCAGCTCA
GGCTCCGCCTTGCAATATGACACACTCATCAGCCTGATGGAGCACCTGAAAGCCTGTGCA
GAGATTGCCGCCCAGCGAACCATCAACTGGCAGAAATTCTGCATCAAAGATGACTCCGTC
CTGTACTTCCTCCTCCAAGTCAGTTTCCTTGTGGATGAGGGCGTGTCCCCAGTGCTGCTG
CAACTGCTCTCCTGTGCTCTGTGCGGCAGCAAGGTGCTCGCTGCACTGGCAGCCTCTTCG
GGATCCTCCAGTGCTTCTTCCTCCTCAGCCCCTGTGGCTGCCAGTTCTGGACAAGCCACA
ACACAGTCCAAGTCTTCCACTAAAAAGAGCAAGAAAGAAGAAAAAGAAAAGGAGAAAGAT
GGTGAGACCTCTGGCAGCCAGGAGGACCAGCTGTGCACAGCTCTGGTGAACCAGCTGAAC
AAATTTGCCGATAAGGAAACCCTGATCCAGTTCCTGCGTTGTTTCCTGTTAGAGTCCAAT
TCTTCCTCGGTGCGCTGGCAGGCCCACTGTCTGACACTGCACATCTACAGAAATTCCAGC
AAATCTCAACAGGAGCTCCTGCTAGATCTGATGTGGTCCATCTGGCCAGAACTCCCAGCC
TATGGTCGTAAGGCTGCCCAGTTTGTGGACCTACTAGGATATTTCTCCCTGAAAACTCCA
CAAACAGAGAAGAAGTTGAAGGAGTATTCACAGAAGGCTGTGGAGATTCTGCGGACTCAA
AACCATATTCTTACCAACCACCCCAACTCGAACATTTATAACACTTTGTCTGGCTTAGTG
GAGTTTGATGGCTATTACCTGGAGAGCGATCCCTGCCTGGTGTGTAATAACCCGGAAGTA
CCGTTCTGTTATATCAAGCTGTCTTCCATTAAAGTGGACACGCGGTACACCACCACCCAG
CAGGTTGTGAAGCTCATTGGCAGTCACACCATCAGCAAAGTGACAGTGAAAATCGGGGAT
CTGAAACGGACCAAGATGGTGCGGACCATCAACCTGTATTATAACAACCGAACCGTGCAG
GCCATCGTGGAGTTGAAAAACAAGCCAGCTCGCTGGCACAAAGCCAAGAAGGTTCAGCTG
ACCCCTGGACAGACAGAGGTGAAGATTGACCTGCCGTTGCCCATTGTGGCCTCCAATCTG
ATGATTGAGTTTGCAGACTTCTATGAAAACTACCAGGCCTCCACAGAGACCCTGCAGTGC
CCTCGCTGTAGTGCCTCGGTCCCTGCCAACCCAGGAGTCTGTGGCAACTGTGGAGAGAAT
GTGTACCAGTGTCACAAATGCAGATCCATCAACTACGATGAAAAGGATCCCTTCCTCTGC
AATGCCTGTGGCTTCTGTAAATATGCCCGCTTCGACTTCATGCTCTATGCCAAGCCTTGC
TGTGCAGTGGATCCCATTGAGAATGAAGAAGACCGGAAGAAGGCTGTATCCAACATCAAT
ACACTTTTGGACAAAGCTGATCGAGTGTATCATCAGCTGATGGGACACCGGCCACAGCTG
GAGAACCTGCTCTGCAAAGTGAATGAGGCAGCTCCAGAAAAGCCACAGGATGACTCAGGA
ACAGCAGGGGGCATCAGCTCCACTTCTGCCAGTGTGAATCGTTACATCCTGCAGTTGGCT
CAGGAGTATTGTGGAGACTGCAAGAACTCTTTTGATGAACTCTCCAAAATCATCCAGAAA
GTCTTTGCTTCGCGCAAAGAGTTGTTGGAATATGACCTACAGCAGAGGGAAGCAGCCACT
AAATCATCCCGGACCTCCGTGCAGCCCACATTCACTGCCAGCCAGTACCGTGCCTTATCC
GTCCTGGGCTGTGGCCACACATCCTCCACCAAGTGCTATGGCTGCGCCTCGGCTGTCACA
GAACATTGTATCACACTACTTCGGGCCCTGGCCACCAACCCAGCCTTGAGGCACATCCTT
GTCTCCCAGGGCCTTATCCGGGAGCTCTTTGATTATAATCTTCGCCGAGGGGCTGCGGCC
ATGCGGGAGGAGGTCCGCCAGCTCATGTGCCTCCTAACTCGAGACAACCCAGAAGCCACC
CAACAGATGAATGACCTGATTATTGGCAAGGTCTCCACAGCCCTGAAGGGCCACTGGGCC
AACCCCGATCTGGCAAGTAGCCTGCAGTATGAAATGCTGCTGCTGACGGATTCTATCTCC
AAGGAGGACAGCTGCTGGGAGCTCCGGTTACGCTGTGCTCTCAGCCTTTTCCTCATGGCT
GTGAACATTAAGACTCCTGTGGTGGTTGAAAACATTACCCTCATGTGCCTGAGGATCTTG
CAGAAGCTGATAAAACCACCTGCTCCCACTAGCAAGAAGAACAAGGATGTCCCCGTTGAG
GCCCTCACCACGGTGAAGCCATACTGCAATGAGATCCATGCCCAGGCTCAACTGTGGCTC
AAGAGAGACCCCAAGGCATCCTATGATGCCTGGAAGAAGTGTCTTCCTATCAGAGGGATA
GATGGCAATGGGAAAGCCCCCAGCAAATCAGAGCTCCGCCATCTCTATTTGACTGAGAAG
TATGTGTGGAGGTGGAAACAGTTCCTGAGTCGTCGGGGGAAGAGGACCTCCCCCTTGGAT
CTCAAACTGGGGCATAACAACTGGCTGCGACAAGTGCTTTTCACTCCAGCAACGCAGGCC
GCACGGCAGGCAGCCTGTACCATTGTGGAAGCTCTAGCCACCATTCCCAGCCGCAAGCAG
CAGGTCCTGGACCTGCTTACCAGTTACCTGGATGAGCTGAGCATAGCTGGGGAGTGTGCA
GCTGAGTACCTGGCTCTCTACCAGAAGCTCATCACTTCTGCGCACTGGAAAGTCTACTTG
GCAGCTCGGGGAGTCCTACCCTATGTGGGCAACCTCATCACCAAGGAAATAGCTCGTCTG
CTGGCCCTGGAGGAGGCTACCCTGAGTACCGATCTGCAGCAGGGTTATGCCCTTAAAAGT
CTCACAGGCCTTCTCTCCTCCTTTGTTGAGGTGGAATCCATCAAAAGACATTTTAAAAGT
CGCTTGGTGGGTACTGTGCTGAATGGATACCTGTGCTTGCGGAAGCTGGTGGTGCAGAGG
ACCAAGCTGATCGATGAGACGCAGGACATGCTGCTGGAGATGCTGGAGGACATGACCACA
GGTACAGAATCAGAAACCAAGGCCTTCATGGCTGTGTGCATTGAGACAGCCAAGCGCTAC
AATCTGGATGACTACCGGACCCCGGTGTTCATCTTCGAGAGGCTCTGCAGCATCATTTAT
CCTGAGGAGAATGAAGTCACTGAGTTCTTTGTGACCCTGGAGAAGGATCCCCAACAAGAA
GACTTCTTACAGGGCAGGATGCCTGGGAACCCGTATAGCAGCAATGAGCCAGGCATCGGG
CCGCTGATGAGGGATATAAAGAACAAGATTTGCCAGGACTGTGACTTAGTGGCCCTCCTG
GAAGATGACAGTGGCATGGAGCTTCTAGTGAACAATAAAATCATTAGTTTGGACCTTCCT
GTGGCTGAAGTTTACAAGAAAGTCTGGTGTACCACGAATGAGGGAGAGCCCATGAGGATT
GTTTATCGTATGCGGGGGCTGCTGGGCGATGCCACAGAGGAGTTCATTGAGTCCCTGGAC
TCTACTACAGATGAAGAAGAAGATGAAGAAGAAGTGTATAAAATGGCTGGTGTGATGGCC
CAGTGTGGGGGCCTGGAATGCATGCTTAACAGACTCGCAGGGATCAGAGATTTCAAGCAG
GGACGCCACCTTCTAACAGTGCTACTGAAATTGTTCAGTTACTGCGTGAAGGTGAAAGTC
AACCGGCAGCAACTGGTCAAACTGGAAATGAACACCTTGAACGTCATGCTGGGGACCCTA
AACCTGGCCCTTGTAGCTGAACAAGAAAGCAAGGACAGTGGGGGTGCAGCTGTGGCTGAG
CAGGTGCTTAGCATCATGGAGATCATTCTAGATGAGTCCAATGCTGAGCCCCTGAGTGAG
GACAAGGGCAACCTCCTCCTGACAGGTGACAAGGATCAACTGGTGATGCTCTTGGACCAG
ATCAACAGCACCTTTGTTCGCTCCAACCCCAGTGTGCTCCAGGGCCTGCTTCGCATCATC
CCGTACCTTTCCTTTGGAGAGGTGGAGAAAATGCAGATCTTGGTGGAGCGATTCAAACCA
TACTGCAACTTTGATAAATATGATGAAGATCACAGTGGTGATGATAAAGTCTTCCTGGAC
TGCTTCTGTAAAATAGCTGCTGGCATCAAGAACAACAGCAATGGGCACCAGCTGAAGGAT
CTGATTCTCCAGAAGGGGATCACCCAGAATGCACTTGACTACATGAAAAAGCACATCCCT
AGCGCCAAGAATTTGGATGCCGACATCTGGAAAAAGTTTTTGTCTCGCCCAGCCTTGCCA
TTTATCCTAAGGCTGCTTCGGGGCCTGGCCATCCAGCACCCTGGCACCCAGGTTCTGATT
GGAACTGATTCCATCCCGAACCTGCATAAGCTGGAGCAGGTGTCCAGTGATGAGGGCATT
GGGACCTTGGCAGAGAACCTGCTGGAAGCCCTGCGGGAACACCCTGACGTAAACAAGAAG
ATTGACGCAGCCCGCAGGGAGACCCGGGCAGAGAAGAAGCGCATGGCCATGGCAATGAGG
CAGAAGGCCCTGGGCACCCTGGGCATGACGACAAATGAAAAGGGCCAGGTCGTGACCAAG
ACAGCACTCCTGAAGCAGATGGAAGAGCTGATCGAGGAGCCTGGCCTCACGTGCTGCATC
TGCAGGGAGGGATACAAGTTCCAGCCCACAAAGGTCCTGGGCATTTATACCTTCACGAAG
CGGGTAGCCTTGGAGGAGATGGAGAATAAGCCCCGGAAACAGCAGGGCTACAGCACCGTG
TCCCACTTCAACATTGTGCACTACGACTGCCATCTGGCTGCCGTCAGGTTGGCTCGAGGC
CGGGAAGAGTGGGAGAGTGCCGCCCTGCAGAATGCCAACACCAAGTGCAACGGGCTCCTT
CCGGTCTGGGGACCTCATGTCCCTGAATCAGCTTTTGCCACTTGCTTGGCAAGACACAAC
ACTTACCTCCAGGAATGTACAGGCCAGCGGGAGCCCACGTATCAGCTCAACATCCATGAC
ATCAAACTGCTCTTCCTGCGCTTCGCCATGGAGCAGTCGTTCAGCGCAGACACTGGCGGG
GGCGGCCGGGAGAGCAACATCCACCTGATCCCGTACATCATTCACACTGTGCTTTACGTC
CTGAACACAACCCGAGCAACTTCCCGAGAAGAGAAGAACCTCCAAGGCTTTCTGGAACAG
CCCAAGGAGAAGTGGGTGGAGAGTGCCTTTGAAGTGGACGGGCCCTACTATTTCACAGTC
TTGGCCCTTCACATCCTGCCCCCTGAGCAGTGGAGAGCCACACGTGTGGAAATCTTGCGG
AGGCTGTTGGTGACCTCGCAGGCTCGGGCAGTGGCTCCAGGTGGAGCCACCAGGCTGACA
GATAAGGCAGTGAAGGACTATTCCGCTTACCGTTCTTCCCTTCTCTTTTGGGCCCTCGTC
GATCTCATTTACAACATGTTTAAGAAGGTGCCTACCAGTAACACAGAGGGAGGCTGGTCC
TGCTCTCTCGCTGAGTACATCCGCCACAACGACATGCCCATCTACGAAGCTGCCGACAAA
GCCCTGAAAACCTTCCAGGAGGAGTTCATGCCAGTGGAGACCTTCTCAGAGTTCCTCGAT
GTGGCCGGTCTTTTATCAGAAATCACCGATCCAGAGAGCTTCCTGAAGGACCTGTTGAAC
TCAGTCCCCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02207</identifier>
            <name>zf-UBR</name>
          </pfam>
          <pfam>
            <identifier>PF13764</identifier>
            <name>E3_UbLigase_R4</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>centrosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ubiquitin-protein transferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein ubiquitination involved in ubiquitin-dependent protein catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>